Twelve years after a breakthrough discovery in his University of California, Berkeley, laboratory, professor of chemical engineering Jay Keasling is seeing his dream come true.
Apr 11, 2013
0
0
Autophagy, the process by which cells that are starved for food resort to chewing up their own damaged proteins and membranes and recycling them into fuel, has emerged as a key pathway that cancer cells use to survive in ...
Apr 8, 2013
0
0
Scientists have identified biomarkers that may help predict whether patients with KRAS-mutated non-small cell lung cancer (NSCLC) will respond to concurrent treatment with an MEK inhibitor and a PI3 kinase inhibitor, a drug ...
Apr 8, 2013
0
0
(HealthDay)— A drug regimen containing two powerful antifungal medicines—amphotericin B and flucytosine—reduced the risk of dying from cryptococcal meningitis by 40 percent compared to treatment with amphotericin B ...
Apr 3, 2013
1
0
Multi-peptide vaccination therapy combined with the low-dose steroid drug dexamethasone shows promise in treating chemotherapy-naive castration resistant prostate cancer (CRPC) patients.
Mar 15, 2013
0
0
People with multiple sclerosis (MS) who were treated with combination therapy did not see significant clinical benefit over those treated with single drug therapy, but combination therapy did reduce the development of new ...
Mar 11, 2013
0
0
A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While ...
Mar 11, 2013
0
0
According to Dr. Samy Suissa, Director of Clinical Epidemiology, Jewish General Hospital, and Professor of Epidemiology, McGill University in Montreal, Canada, "treating physicians need to consider the clinical effectiveness ...
Mar 5, 2013
0
0
Hailed as a major step forward in the effort to develop targeted cancer therapies, a recently approved drug for the most common type of skin cancer has been a mixed blessing for patients. Although the initial response is ...
Feb 27, 2013
0
0
People with HIV are less able to recognise facial emotion than non-infected people finds a study published in the launch edition of BioMed Central's open access journal BMC Psychology. Reduction in their ability to recognise ...
Feb 26, 2013
0
0
